Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: a review

Tarik A Elhadd, Abdallah A Al-Amoudi, Ali S Alzahrani, Tarik A Elhadd, Abdallah A Al-Amoudi, Ali S Alzahrani

Abstract

Diabetes mellitus is emerging as a major public health problem in Saudi Arabia in parallel with the worldwide diabetes pandemic, which is having a particular impact upon the Middle East and the third world. This pandemic has accompanied the adoption of a modern lifestyle and the abandonment of a traditional lifestyle, with a resultant increase in rates of obesity and other chronic non-communicable diseases. The indigenous Saudi population seems to have a special genetic predisposition to develop type 2 diabetes, which is further amplified by a rise in obesity rates, a high rate of consanguinity and the presence of other variables of the insulin resistance syndrome. We highlight the epidemiology, clinical and complications profiles of diabetes in Saudi people. Diabetes is well studied in Saudi Arabia; however, there seems to be little research in the area of education and health care delivery. This is of paramount importance to offset the perceived impact on health care delivery services, to lessen chronic diabetes complications, and to reduce the expected morbidity and mortality from diabetes.

References

    1. Amos A, McCarthy D, Zimmit P. The rising global burden of diabetes and its complications: Estimates and projections to the year 2010. Diabet Med. 1997;14:S1–S85.
    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes estimates for the year 2000 and projection for 2030. Diabetes Care. 2004;27(5):1047–53.
    1. Ledward RS. Initial findings in a new obstetric unit in Saudi Arabia. Trop Doct. 1982;12(2):63.
    1. Bacchus RA, Bell JR, Madkour M, Kilshaw The prevalence of diabetes mellitus in male Saudi Arabs. Diabetologia. 1982;23(4):330.
    1. Al-Nuaim AR. Prevalence of glucose intolerance in urban and rural communities of Saudi Arabia. Diabet Med. 1997;14(7):595–602.
    1. Al-Nozha MM, Al-Matouq MA, Al-Mazrou YY, et al. Diabetes in Saudi Arabia. Saudi Med J. 2004;25(11):1603–10.
    1. el-Hazmi MA, al-Swailem AR, Warsy SA, al-Swailem AM, Sulimani R, al-Mashari AA. Consanguinity among Saudi Arabian population. J Med Genetics. 1995;32(8):623.
    1. Cook GC. Rapid glucose absorption in Arabs in Saudi Arabia compared in that in Africans in Zambia. Br Med J. 1976;201(6011):688–89.
    1. Gupta OP, Joshi MH, Dave SK. Prevalence of diabetes mellitus in India. Adv Metabol Disord. 1978;9:147–65.
    1. Fatani HH. Prevalence of diabetes mellitus in rural Saudi Arabia. Diabetes Care. 1987;10(2):180.
    1. Anukote CC. Epidemiology studies of diabetes mellitus in Saudi Arabia-Part 1-screening of 3158 males in King Saud University. J Soc Health. 1990;110(6):210–03.
    1. el-Hazmi MA, Warsy AS, al-Swailem AR, al-Swailem AM, Sulimani R, Al Meshari AA. Diabetes mellitus and impaired glucose tolerance in Saudi Arabia. Annals Saudi Med. 1996;16(4):381–385.
    1. el-Hazmi MA, Warsy AS. Prevalence of overweight and obesity in diabetic and non-diabetic Saudi Arabians. East Mediterr Health J. 2000;6(2–3):276–82.
    1. Al-Nuaim RA. Effects of overweight and obesity on glucose intolerance and dyslipidemia in Saudi Arabia: an epidemiological study. Diabet Res Clin Pract. 1997;36(3):181–91.
    1. Salman H, Abanamy A, Ghassan B, Khalil M. Childhood diabetes in Saudi Arabia. Diabet Med. 1991;8(2):176.
    1. Kulyalat NA, Narchi H. A twelve year study of the incidence of childhood Type-1 diabetes mellitus in the Eastern Province of Saudi Arabia. J Ped Endocrinol Metabol. 2000;13(2):135–40.
    1. Fonseca V, Laajam MA, Tongia RK. Non-ketotic diabetes mellitus in young non obese Saudi Arabians. East Afr Med J. 1985;62(1):21–25.
    1. Famuyiwa OO, Sulimani RA, Laajam MA, Al-Jasser SJ, Mekki MO. Diabetes mellitus in Saudi Arabia: the clinical pattern and complications in 1000 patients. Ann Saudi Med. 1992;12:140–51.
    1. Alhussein KA, Rama NR, Ahmed M, Rozemullar E. HLA-DPBI0401 is associated with dominant protection against Type-1 diabetes in general Saudi population in subjects with risk DR/DQ haplotype. Eur J Immunogenet. 2003;36(2):115.
    1. Abdullah MA, Salman H, Bahakim H, Gad al Rab MO, Halim K, Abanmy A. Antithyroid and other organ-specific antibodies in Saudi Arab diabetic and normal children. Diabet Med. 1990;7(1):50–52.
    1. Qari F, Damnan S. Schmidt’s syndrome in a Saudi family. Saudi Med J. 2000;21(1):93–95.
    1. el-Hazmi MA, al-Swailem AR, al-Fawaz I, Warsy AS, al-Swailem AM. Diabetes mellitus in children suffering from beta thalssemia. J Trop Pediatr. 1994;40(5):261.
    1. Taha D, Barbar M, Kanaan, Williamson Balfe J. Neonatal diabetes mellitus, congenital hypothyroidism, hepatic fibrosis, polycystic kidneys and congenital glaucoma: a new autosomal recessive syndrome. Am J Med Genet. 2003;122A(3):269.
    1. Woodhouse NJ, Sakatti N. A syndrome of hypogonadism, alopecia, diabetes mellitus, mental retardation, deafness and ECG abnormalities. J Med Genet. 1983;20(3):216.
    1. AlShawaf T, Akeil A, Mograby SA. Gestational diabetes and impaired glucose tolerance in Riyadh. Br J Obstet Gyanecol. 1988;(1):84–90.
    1. Mwambingen FT, Al Meshari AA, Akeil A. The problem of grandmultiparity in current obstetric practice. Int J Obstet Gynaecol. 1988;26(3):355.
    1. Khawja SS, AlSuleiman SA, al-Sibai MH. Screening for gestational diabetes in a teaching hospital in Saudi Arabia. Aust N Z Obstet Gynaecol. 1989;29(3pt1):209–11.
    1. al-Teheawy MM. Prenatal care in primary health care centres of Al-Hassa, Saudi Arabia. J Egypt Public Health Assoc. 1992;67(1–2 PubMed):37–51.
    1. Nasrat HA, Salih M, Ardawi M, Ghafouri H. Outcome of pregnany in diabetic mothers. Into J Gynaecol Obstet. 1993;10(8):29.
    1. Nasrat HA, Fageeh W, Abalkail B, Yamani T, Ardawi M. Determinant of pregnancy outcome in patients with gestational diabetes. Int J Gynaecol Obstet. 1996;53(2):117.
    1. Subande AA, Al-Bar A, Archibong EL. Diabetes and perinatal loss. A continuing problem. Saudi Med J. 2000;21(2):161–63.
    1. El Mallah KO, Narch H, Kulyate NA, Shaban MS. Gestational and pregestational diabetes. Comparison of maternal characteristics and outcome. Int J Gynaecol Obstet. 1997;58(2):203.
    1. Narchi H, Kulaylat NA. High incidence of Down’s Syndrome in infants of diabetic mothers. Arch Dis Child. 1997;77(3):242.
    1. O’Dea K. Westernization and non-insulin dependent diabetes in Australian aborigines. Ethn Dis. 1991;1(2):171–187.
    1. Anokute CC. Suspected synergism between consanguinity and familial aggregation in type-2 diabetes in Saudi Arabia. J R Soc Health. 1992;112(4):167.
    1. AlNuaim A. High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population aged 30–64 years. Int J Cardiol. 1997;62(3):227.
    1. AlRajeh A, Awada A. Stroke in Saudi Arabia. Cerebrovasc Dis. 2002;13(1):3.
    1. Osman AK, Al-Nozha MM. Risk factors of coronary artery disease in different regions of Saudi Arabia East. Mediterr Health J. 2000;6(2–3):465–74.
    1. AlKhadra AH. Clinical profile of young patients with acute myocardial infraction in Saudi Arabia. In J Cardiol. 2003;91(1):9.
    1. Alhumaidi MA. Probability of coronary artery disease among patients attending primary health care centres in southwest Saudi Arabia. Ethn Dis. 2000;10(3):350.
    1. Kuskowska X, Wolk A, Rossners Y. Prevalence of overweight in Sweden: a cross-sectional study of representative world population. J Int Med. 1990;227:241–246. PubMed.
    1. Al-Turki YA. The prevalence of overweight and obesity amongst hypertensive and diabetic adult patients in primary health care. Saudi Med J. 2000;21(4):340–43.
    1. Al Harithy RN, Al Ghamdi S. Serum resistin, adiposity and insulin resistance in Saudi women with type-2 diabetes. Ann Saudi Med. 2005;25(4):283.
    1. Aldahgri N, Chetty R, McTerran PG, Al-Rubean K, Al-Attas O, Jones A, Kumar S. Serum resistin is associated with C-reactive protein & LDL cholesterol in type-2 diabetes and coronary artery disease in Saudi population. Cardiovasc Diabetol. 2005;4(1):10–14.
    1. Akbar DH. Is hypertension common in hospitalized type-2 diabetic patients? Saudi Med J. 2001;22(2):139–41.
    1. Warsy AS, el-Hazmi MA. Diabetes mellitus, hypertension and obesity: common multifactorial disorders in Saudi. East Meditter Health J. 1999;5(6):1236–42.
    1. Al-Shammari SA, Ali M, al-Shammari A, al-Maatoug M, Tennier A, Armstrong K. Blood lipid concentration and other cardiovascular risk factors among Saudi’s. Fam Pract. 1994;11(2):153–58.
    1. AlRajih S, Larbi EB, Bademosi O, et al. Stroke egister: experience from the Eastern Province of Saudi Arabia. Cerebrovasc Dis. 1998;8(2):86.
    1. Awada A, Al Rajeh S. The Saudi stroke data bank. Analysis of the first 1000 cases. Acta Neurol Scand. 1999;100(4):265–69.
    1. Qari FA. Profile of stroke in a teaching university hospital in the Western region. Saudi Med J. 2000;11:1030–33.
    1. AlRajeh S, Awada A. Stroke in Saudi Arabia. Cerebrovasc Dis. 2002;13(1):3. PubMed -8.
    1. Al Zahrani HA. The distribution of peripheral arterial disease in a defined population of elderly high risk Saudi patients. Int Angiol. 1997;16(2):123.
    1. AlNozha M, Aldaghri N, Bartlett WA, et al. Serum homocysteine concentration is related to diabetes mellitus but not to coronary artery disease in Saudi Arabia. Diabetes Ob Metab. 2002;4(2):118–23.
    1. Ajabnoor MA, Al-Ama MN, Banjar Z, Rafee AA, Sheweita SA. Homocysteine levels and other biochemical parameters of cardiovascular disease in patients with diabetes. Med Sci Monit. 2003;9(12):CR523.
    1. Elhadd TA, Neary R, Abdu TA, et al. Influence of hormonal changes during the normal menstrual cycle in young healthy women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. Int Angiol. 2004;22(3):222.
    1. Akbar DH. The Effect of metformin and sulphonylurea on c-reactive protein in well controlled patients with type-2 diabetes with metabolic syndrome. Endocrine. 2003;20(3):215.
    1. Abu El Asrar AM, Al-Rubean KA, Al-Amro SA, Kangave D. Risk factors for diabetic retinopathy among Saudi diabetics. Int Ophthalmol. 1998–1999;22:155–61. (PubMed)
    1. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of IDDM. New Eng J Med. 1993;329:877–986.
    1. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes. Lancet. 1998;352(9131 PubMed):837–53.
    1. Abu El Asrar AM, Al-Rubean KA, Al-Amro SA, Moharam OA, Kangave D. Retinopathy as a predictor for other diabetic complications. Int Ophthalmol. 2001;24(1):1.
    1. Alghadyan AA. Retinal vein occlusion in Saudi Arabia. Possible role of dehydration. Ann Ophthalmol. 1993;25(10):394–98.
    1. Akbar DH, Mira SA, Zawawi TH, Malibary HM. Subclinical neuropathy a common complication in Saudidiabetics. Saudi Med J. 2000;21(5):433–37.
    1. Fonseca V, Laajam MA, Tongia RK. Asymptomatic autonomic neuropathy in Saudi diabetics. Saudi Med J. 1985;6(1):38–42.
    1. Tongia RK, Fonseca V, Laajam MA. Abnormal systolic time interval in asymptomatic Saudi diabetics. Saudi Med J. 1984;5:415–20.
    1. Neilsen JV. Peripheral neuropathy, hypertension, foot ulcers and amputations among Saudi Arabian patients with Type-2 diabetes. Diabetes Res Clin Pract. 1998;41(1):63–69.
    1. Abbott CA, Garrow AP, Morris J, Van Ross ER, Boulton AJ. North-West diabetes foot care study. Foot ulcer risk is lower in South Asian and Afro-Caribbean compared with Europeans patients in UK. Diabetes Care. 2005;28(8):1869. PubMed -75.
    1. al Qidawi SA, Khan MA, Hussein SR, Malik MS. Diabetic neuroarthropathy. Saudi Med J. 2001;22(2):42–47.
    1. Qari FA, Akbar DH. Diabetic foot: presentation and treatment. Saudi Med J. 2000;21(5):443–46.
    1. El Sakka AL, Tayeb KA. Erectile dysfunction risk factors in non-insulin dependent diabetic Saudi patients. J Urol. 2003;169(3):1043.
    1. Al Helali NS, Abolfotouh MA, Ghanem HM. Pattern of erectile dysfunction in Jeddah city. Saudi Med J. 2001;22(1):34–8.
    1. Onuora VC, Koko AH, Patil MG. Management of impotence in a developing country. East African Med J. 1995;72(7):415–57.
    1. Al Khader AA. Impact of diabetes on renal disease in Saudi Arabia. Nephrol Dialysis Transplant. 2001;16:2132–35.
    1. Mitwalli A, Al-Swailem AR, Aziz KMS, et al. Etiology of end stage renal disease in two regions of Saudi Arabia. Saudi J Kidney Dis Transplant. 1997;6(1):16–20.
    1. AlZaid A, Sobki S, De Silva V. Prevalence of microalbuminuria in Saudi Arabian with non-insulin dependent diabetes: a clinic based study. Diabetes Res Clin Pract. 1994;26:115–120.
    1. Al-Homrany MA, Abdelmoneim I. Significance of proteinuria in type-2 diabetic patients treated at a primary health care centre in Abha City, Saudi Arabia. West Afr J Med. 2004;22(3):211–14.
    1. Nelson D, Bennet P, Beck G. Development and progression of renal disease in Pima Indians with NIDDM. N Eng J Med. 1996:335–36.
    1. SCOT (Saudi Committee of Organ Transplantation) Annual Report. Kingdom of Saudi Arabia Ministry of Health; 1999.
    1. Hussein M, Moeji J, Ronj’leh H, El-Sayed H. Observation in a Saudi Arabian dialysis population over 13 years period. Nephrol Dial Transp. 1994;9:1072–76. PubMed.
    1. Jondeby M, Delos Santos G, Al Ghamdi A, et al. Caring for hemodialysis patients: present, past and future. Saudi Med J. 2001;22:199–204.
    1. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis-C virus during long-term haemodialysis. Swiss Med Wkly. 2003;133(45–46 PubMed):611–18.
    1. Souqiyyeh M, Shaheen F, Sheikh I, et al. Diabetes and renal transplantation: Saudi experience. Saudi J Kidney Dis Transplant. 2000;11:25–30. PubMed.
    1. Anokute CC. Suspected synergism between consanguinity and familial aggregation of Type-2 diabetes in Saudi Arabia. J R Soc Health. 1992;112(4):167.
    1. Alawamy BH. Thalassaemic syndromes in Saudi Arabia: metanalysis of local studies. Saudi Med J. 2000;21(1):8–17.
    1. Niazi GA. Glucose 6 phosphate dehydrogenase deficiency and diabetes mellitus. Int J Haematol. 1991;54(4):295–98.
    1. Sulimani RA, Famuyiwa FO, Laajam MA. Diabetes mellitus and Ramadan fasting: the need for critical appraisal. Diabet Med. 1988;5(6):589–91.
    1. Uysal AR, Erdogan MF, Sahin G, Kamel N, Erdogan G. Clinical and metabolic effects of fasting in 41 type-2 diabetic patients during Ramadan. Diabetes Care. 1998;31(11):2033.
    1. Al-Arouj M, Bouguera R, Buse J, Al-Rubean KA, Hassanien M, Ibrahim M, et al. Recommendation for management of diabetes during Ramadan. Diabetes Care. 2005;28(9):2305.
    1. Elhadd TA, Al-Amoudi AA. Recommendation for management of diabetes during Ramadan. The need for scientific research and patient education. Diabetes Care. 2006;29(3) PubMed 744–45.
    1. Lajaam MA. Ramadan fasting and non-insulin dependent diabetes: effect on metabolic control. East Afr Med J. 1990;67(10):732–36.
    1. Elhadd TA, Bissar LS, AlGhamdi SMG, Bashir M, Al-Amoudi AA. Low education provided to diabetic patients for fasting Ramadan: a questionnaire survey. 87th Meeting of American Endocrine Society 2005; San Diego, CA, USA. pp. P3–519. (Abstract)
    1. AlGhamdi SM, Akbar HO, Qari YA, Fathaldin OA, Al Rashed RS. Patter of admission to hospitals during Muslim pilgrimage (Hajj) Saudi Med J. 2003;24(10):1073–76.
    1. Saxena AK, Panhotra BR. The susceptibility of patients with type-2 diabetes to hepatitis-C virus during long-term haemodialysis. Swiss Med Wkly. 2003;133(45–46 PubMed):611–16.
    1. Akbar DH, Siddique AM, Ahmed MM. Prevalence of type-2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia. Med Princ Pract. 2002;11(2):82. PubMed -85.
    1. Makeen AM. The association of infective hepatitis type A and diabetes mellitus. Trop Geogr Med. 1992;44(4):362–64.
    1. Oli JM, Nwokolo C. Diabetes after infectious hepatitis: a follow up study. Br Med J. 1979;1(6168):926–27.
    1. Al Jahdali H, AlZahrani K, Amene P, Memish Z, AlShemmri A, Moamary M, Alduhaim A. Clinical aspects of military tuberculosis in Saudi adults. Int J Tuberc Lung Dis. 2000;4(3):252–55.
    1. Bukhary ZA, AlRajeh AA. Extrapulmonary tuberculosis: clinical presentation and outcome. Saudi Med J. 2004;25(7):881–85.
    1. Shohaib S, Scrimgreor E, Shaeyra P. Tuberculosis in active dialysis patients in Jeddah. Am J Neph. 1999;19:34–37.
    1. Al Rowis N. Herbal medicine use in treatment of diabetes mellitus. Saudi Med J. 2002;23(1):1327–31.
    1. Al Saeedi M, ElZubier AG, Bahnassi AA, Al-Dawood KM. Pattern and belief and the use of traditional remedies by diabetic patients in Mecca, Saudi Arabia. East Meditter Health J. 2003;9(1–2):99–107.
    1. Bugusz MJ, Al Tufail M, Hassan H. How natural are natural Remedies? A Saudi. Adverse Drug Reaction Toxicology Rev. 2002;21(4):219.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren